Osanni Bio
Scaled Innovation of Transformative Medicines
San Francisco, United States · Founded 2023 · $230.0M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2023
- Business Model
- B2B
- Website
- osanni.bio
- Total Funding
- $230.0M
- Last Round
- $190.0M Venture RoundJun 2026
- Rounds
- 2
About
Osanni Bio is a San Francisco-based development-stage therapeutics company that applies a biodesign-driven innovation engine to discover and develop novel therapies in ophthalmology and cardiology. The company's model centers on building specialized affiliate spinoff companies around validated drug targets, funded with $190 million in Series B financing led by Patient Square Capital.
Summary
Osanni Bio is a Biotech company based in San Francisco, United States, founded in 2023. It has raised $230.0M in total across 2 rounds, most recently a $190.0M Venture Round round in Jun 2026. Investors include Invus.
Funding History
Sign up to view the funding chart
Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.
Jun 2026
Sign up to see all 2 rounds
Venture Round — per-round amounts, valuations, and who invested in each round.
Investors
Similar Companies
China's leading blood products manufacturer
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/osanni-bio"><img src="https://indexed.vc/api/badge/company/osanni-bio" alt="Osanni Bio on Indexed.vc" width="260" height="76" /></a>